A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE2
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
- Status
- COMPLETED
- Phase
- PHASE2
S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1